BC Megestrol Suspension (Megestrol Acetate)

Adult dose

(Tablets) 1. Breast cancer: Administer megestrol acetate orally at a total daily dose of 160 mg in 4 divided doses (40 mg, 1 tablet per dose, 4 times daily). 2. Endometrial cancer: Administer this medicine orally at a total daily dose of 40～320 mg in divided doses. The treatment period should be considered adequate to assess the effect of this medicine; continue administration for at least 2 months. (Suspension) Shake well and take megestrol acetate at a total daily dose of 800 mg (20 mL). In clinical trials, clinical effects were demonstrated with a daily dose of 400～800 mg (10∼20 mL) of this medicine.

This medication can be very dangerous to the fetus if used by pregnant women, so pregnant women or women who may become pregnant should not take it. Prolonged use may lead to newly developed diabetes or exacerbation of existing diabetes, as well as risk of adrenal insufficiency. Symptoms such as hypotension, nausea, vomiting, dizziness, and weakness may occur if adrenal insufficiency develops, so immediate consultation with a healthcare provider is necessary. Individuals with allergies or a history of hypersensitivity to this medication should not take it. Caution should be exercised in patients with a history of thromboembolism or diabetes, as diabetes symptoms may worsen. During usage, side effects such as diarrhea, rash, abdominal bloating, nausea, vomiting, headache, and insomnia may occur, and severe symptoms should be discussed with a doctor. This drug is intended for the treatment of weight loss, so it should be used only after accurately identifying the cause, and prolonged use may increase the risk of respiratory infections. Women who are pregnant or breastfeeding should not use this medication, and breastfeeding should be stopped if nursing. Safety and efficacy for pediatric patients have not been established, so it should not be used in children. No specific harmful symptoms have been reported in case of overdose; however, in the event of excessive intake, dialysis may not be effective, hence immediate notification to a healthcare provider is required. This medication should be kept out of reach of children, and transferring it to other containers should be avoided as it may cause accidents or degradation of quality.

• Diarrhea
• Erectile Dysfunction
• Rash
• Abdominal Distension
• Hypertension
• Asthenia
• Insomnia
• Nausea
• Anemia
• Fever

This medication may be sensitive to air or moisture, so it should be stored in a closed container. It is recommended to maintain room temperature between 15 and 25 degrees Celsius. This will help maintain the drug's efficacy and safety for a longer period.

Appearance

A white to cream-colored suspension with an orange flavor and scent contained in a pouch, easily dispersed when shaken.

Package unit

20 milliliters/pouch [x 12], 20 milliliters/pouch [x 20]